FindTrial
Sign In

Use of Kailas Jeevan in prevention and treatment of Stretch Marks in pregnancy

Study of Clinical Safety & Efficacy of Kailas Jeevan as Prophylaxis in Kikkisa with special reference to Straie Gravidarum

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/07/020306
Enrollment
100
Registered
2019-07-22
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L906- Striae atrophicae

Interventions

Intervention1: Kailas Jeevan: Local Application 5 to 10 gms twice a day for 3 months during 24 to 36 weeks of pregnancy Control Intervention1: NA: NA

Sponsors

Ayurved Sumshodhanalaya Pune Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Primi Pataients between 24 to 36 weeks of Prgnancy. Daignosed Kikkisa (Straie Gravidarum) Patients will be seleceted for Treatment

Exclusion criteria

Exclusion criteria: Pregnant Woman with any skin disorder. Not applied before 24 weeks of Pregnancy

Design outcomes

Primary

MeasureTime frame
Improvement in symptoms of Kikisa - Straie Gravidaum viz. itching, redness, burning . Daveys ScoreTimepoint: Follow ups after 15,30,45,60 days & 3 months—

Secondary

MeasureTime frame
Reduction in Straie Gravidaum as per Daveys Score. Assessement of Application of Kailas Jeevan as ProphylaxisTimepoint: Follow ups 15,30,45,60 days & 3 months—

Countries

India

Contacts

Public ContactDr S S Mohite

Bharati Vidyapeeth Deemed University College of Ayurved

dr.ssmohite@gmail.com9822004562

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026